Research Article

Basal-Like Phenotype in a Breast Carcinoma Case Series from Sudan: Prevalence and Clinical/Pathological Correlations

Table 3

Basal cytokeratins status according to tumor grade, tumor size ( 𝑇 ), ER, PgR, combined ER/PgR, Her-2/neu, and histology.

CK5/6+ and/or CK17+, Number (%)
PositiveNegativeχ 2

Grade
 g29 (20)26 (39)4.72 ( 𝑃 < . 0 3 )
 g337 (80)41 (61)
Tumor size ( 𝑇 )
𝑇 14 (9)6 (9)0.67 ( 𝑃 = . 8 8 )
𝑇 221 (45.5)25 (37)
𝑇 37 (15)13 (19.5)
𝑇 45 (11)7 (10.5)
 NA9 (19.5)16 (24)
ER
 ER+21 (46)50 (75)9.8 ( 𝑃 < . 0 0 2 )
 ER−25 (54)17 (25)
PgR
 PgR+23 (50)51 (76)8.2 ( 𝑃 = . 0 0 4 )
 PgR−23 (50)16 (24)
Combined ER/PgR
 ER+ and/or PgR+25 (54)58 (87)14.5 ( 𝑃 < . 0 0 0 2 )
 ER−/PgR−21 (46)9 (13)
Her-2/neu
 Her-2/neu+10 (22)14 (21)0.012 ( 𝑃 = . 9 )
 Her-2/neu−36 (78)53 (79)
Histology
 IDC*45 (98)56 (84%)6.3 ( 𝑃 = . 1 7 )
 ILC°5 (7%)
 Mucinous1 (2)4 (6%)
 Medullary1 (1.5%)
 Paget’s disease1 (1.5%)

NA: not available tumor size data in 25 cases, *IDC: infiltrating ductal carcinoma, °ILC: infiltrating lobular carcinoma.